Physician profile
Anne E Conner
NPI 1689681835
$1,799.93
in general payments reported to CMS, 2019-2025
21 companies · $239 in 2025
The $239 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $826 · 2023: $465 · 2024: $269 · 2025: $239.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $974.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $973.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $384.85 | 2022-2025 | |
| Novo Nordisk INC | $326.07 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $187.63 | 2022-2025 | |
| Glaxosmithkline, LLC. | $118.21 | 2022-2024 | Arexvy, Bexsero, Shingrix |
| Lilly USA, LLC | $106.98 | 2022-2023 | Mounjaro |
| Bayer Healthcare Pharmaceuticals INC. | $100.64 | 2022-2025 | |
| Medtronic, INC. | $93.53 | 2024-2025 | Intellis Adaptivestim |
| Novartis Pharmaceuticals Corporation | $86.92 | 2023-2024 | |
| Amgen INC. | $76.35 | 2023-2025 | Otezla, Repatha, Otezla |
| Boehringer Ingelheim Pharmaceuticals, INC. | $47.18 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $45.78 | 2023 | Rexulti |
| Biohaven Pharmaceutical Holding Company Ltd. | $33.13 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $31.05 | 2022-2023 | Eliquis |
| Sumitomo Pharma America, INC. | $27.65 | 2023 | Aptiom |
| Astrazeneca Pharmaceuticals Lp | $25.33 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $23.41 | 2022 | |
| Janssen Pharmaceuticals, INC | $19.69 | 2022 | |
| Abbott Laboratories | $18.29 | 2022 | |
| Almatica Pharma LLC | $18.00 | 2023 | Loreev Xr |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $15.82 | 2022 | |
| Sanofi-Aventis U.S. LLC | $13.42 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anne Conner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.